For the Inventor, By the Inventor

Enter assignee name

Bengaluru, India

Sami-sabinsa Group Limited

USPTO Granted Patents = 15

EPO Patents = 8

Forward Citations = 1

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Kalyanam Nagabhushanam (15 out of 97 patents)

Muhammed Majeed (9 out of 117 patents)

Muhammed Majeed (6 out of 9 patents)

4. Lakshmi Mundkur (5 out of 17 patents)

5. Sarang Bani (4 out of 14 patents)

6. Anjali Pandey (4 out of 16 patents)

7. Sivakumar Arumugam (4 out of 26 patents)

8. Shaheen Majeed (3 out of 15 patents)

9. Kirankumar Beede (3 out of 5 patents)

10. Furqan Ali (2 out of 23 patents)

11. Rajendran Ramanujam (2 out of 13 patents)

12. Nooruddin Thajuddin (1 out of 1 patent)

13. Krishnamurthy Kulithalai Viswanathan (1 out of 1 patent)

14. Samuel Thomas Manoharan (1 out of 1 patent)

15. John Adams Sebastian (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 12465585 - Compositions for the management of seizure induced neurotoxicity (2025-11-11),

2. 12257274 - Fructophilic lactic acid producing bacteria (2025-03-25),

3. 12233032 - Compositions for management of polycystic ovary syndrome (2025-02-25),

4. 12053500 - Compositions for management of acute nephrotoxicity (2024-08-06),

5. 11957728 - Compositions for targeting receptor for advanced glycation end-products (RAGE) in a chronic inflammatory condition (2024-04-16),

6. 11925606 - Compositions for managing chronic obstructive pulmonary disease (2024-03-12),

7. 11744807 - Therapeutic compositions and methods for pulmonary fibrosis (2023-09-05),

8. 11707438 - Curcuminoid composition for therapeutic management of metabolic syndrome (2023-07-25),

9. 11491119 - Curcuminoid composition and its therapeutic potential in managing lung fibrosis (2022-11-08),

10. 11419906 - Method and composition for therapeutic management of gluten intolerance (2022-08-23),

11. 11413318 - Compositions and methods for management of atrophic gastritis and colitis (2022-08-16),

12. 11351102 - Plant actives and their anti-pollution effects thereof (2022-06-07),

13. 11299706 - Microbial bioconversion of curcuminoids to calebin-A (2022-04-12),

14. 11202810 - Stable probiotic composition for the management of lactose intolerance (2021-12-21),

15. 10959980 - Bioactive molecules from oroxylum indicum and their therapeutic applications (2021-03-30),

Sami-Sabinsa Group Limited is a leading global nutraceutical and cosmeceutical company, specializing in natural ingredients and formulations. With a strong focus on research and development, they have created innovative products that promote health and wellness. Their diverse portfolio includes dietary supplements, skincare products, and specialty chemicals. The company is committed to sustainability and ethical business practices.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

15 Patents

#20 in Bengaluru

#122 in India

#38,669 in the World

Bengaluru, India

Sami-sabinsa Group Limited

Forward Citations = 1

22 inventors:

Kalyanam Nagabhushanam (15 out of 97 patents)

Muhammed Majeed (9 out of 117 patents)

Muhammed Majeed (6 out of 9 patents)

4. Lakshmi Mundkur (5 out of 17 patents)

5. Sarang Bani (4 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…